Search results - 2 results

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

in order to guide decisions on DAA  reimbursement. METHODS: Residual sera were collected through clinical laboratories. We collected data on age, sex and district. HCV antibody status was determined ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

are scarce, and particularly for people who inject drugs. The current study refines the existing HCV estimates by focussing on diagnostic HCV testing practices for this population at risk. METHODS: The ...

QR code

QR code for this page URL